![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Sunday, March 13, 2022 9:53:20 AM
For the nine-month period ended September 30, 2021, the Company had a net loss of $ 3,129,731 (2020 -
$4,715,771), an accumulated deficit of $51,810,968 (December 31, 2020 - $48,506,467) and has historically
used net cash in operations. These conditions indicate the existence of material uncertainties that casts
substantial doubt about the Company’s ability to continue as a going concern. The Company's ability t o
continue as a going concern is dependent upon achieving a profitable level of operations and obtaining
additional financing, neither of which is assured. The Company has been able to raise capital to continue to
market its products and continues to develop sales opportunities that could result in additional sales of its
products in the future. These condensed interim consolidated financial statements do not give effect to any adjustments which may be necessary should the Company be unable to continue as a going concern and be
required to realize its assets and discharge its liabilities in other than the normal course of business and at
amounts different from those reflected in the accompanying condensed interim consolidated financial
statements. These adjustments could be material.
The Company’s objective is to maintain a sufficient capital base to support future research, development and
strategic business initiatives allowing the Company to invest in its future and maintain investor, creditor and
market confidence. Sales of the TLC-2000, the Company’s existing product line have not met expectations and
have not been sufficient in and of themselves to enable the Company to fund all its continuing development
and commercialization efforts and, accordingly, management is pursuing alternate financing sources to fund
the Company’s development and commercialization efforts. The Company has successfully raised capital
through equity offerings in 2019 however, there is no guarantee that the Company will be able to raise
additional capital on terms and conditions agreeable to the Company.
https://theralase.com/wp-content/uploads/2021/11/Q321-Financial-Statements-Final-3.pdf
That doesn't sound to good to me, not much cash left and sales of TLC-2000 not going well.
I am thinking about buying a small position but above statements worries me.
I guess the bladder cancer laser treatment is the hope for this company for survival and big earnings.
FEATURED Nightfood Holdings Signs Letter of Intent for All-Stock Acquisition of CarryOutSupplies.com • Jul 17, 2024 1:00 PM
Kona Gold Beverages Reaches Out to Largest Debt Holder for Debt Purchase Negotiation • KGKG • Jul 17, 2024 9:00 AM
Avant Technologies Welcomes Back Former CEO with Eye Toward Future Growth and Expansion • AVAI • Jul 17, 2024 8:00 AM
HealthLynked Expands Telemedicine Nationwide • HLYK • Jul 17, 2024 8:00 AM
Peer To Peer Network aka Mobicard™ Launches AI Investor Chatbot Boosting Engagement & Lead Generation on Ihub • PTOP • Jul 15, 2024 8:30 AM
Greenlite Ventures Announces AI Integration into No Limit Platforms • GRNL • Jul 15, 2024 8:00 AM